Leuprorelin-containing depot products: need to strictly follow instructions for reconstitution and administration to reduce the risk of handling errors that may result in lack of efficacy

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Active substance
leuprorelin
Procedure number
EMEA/H/A-31/1486
Regulatory outcome
Variation
DHPC type
Referral - Article 31
Referral name
Leuprorelin-containing depot medicinal products

How useful was this page?

Add your rating